PTC Therapeutics, Inc. (PTCT) announced that the sepiapterin MAA for PKU has been validated and accepted for review by the EMA. The sepiapterin MAA includes data from the phase 3 APHENITY trial.
Asahi Kasei said it will offer the shareholders of Calliditas Therapeutics to acquire the shares of Calliditas for the purpose of making Calliditas a subsidiary of Asahi Kasei through a voluntary tender offer for Calliditas.
Vista Outdoor Inc. (VSTO) said its Board, following consultation with its financial and legal advisors, has rejected the unsolicited indication of interest received from MNC Capital on March 25, 2024 pursuant to which MNC expressed interest in acquiring Vista Outdoor in an all-cash transaction for $37.
Infant formula is being recalled after the Food and Drug Administration realized it wasn't properly evaluated to see if they meet the agency's standards.